The CBX5 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from HEK293T cells, designed to disrupt the CBX5 gene encoding heterochromatin protein 1 alpha (HP1??). This heterogeneous pool captures a range of loss-of-function edits, avoiding clonal bias and providing a robust model for studying HP1??-dependent pathways. The polyclonal format ensures reproducible population-level analyses of heterochromatin disruption.
HEK293T cells are human embryonic kidney epithelial cells expressing the SV40 large T antigen, which facilitates high-level protein expression and viral packaging. Their adherent growth and straightforward culture conditions make them a versatile platform for gene-editing applications, including knockout studies of chromatin regulators.
CBX5 functions as a key reader of H3K9me2/3 marks via its chromodomain, oligomerizing to compact chromatin and silence transcription. It is regulated by methyltransferases SUV39H1, SUV39H2, and SETDB1, and interacts with LBR, KAP1 (TRIM28), HDAC1/2, POGZ, and CTCF to form repressive complexes. Downstream, CBX5 represses targets such as CDKN1A (p21) and repetitive elements, linking heterochromatin maintenance to cell cycle control and genome stability. Its loss disrupts these networks, altering gene silencing and chromatin architecture.
In the HEK293T background, CBX5 knockout is anticipated to impair heterochromatin organization, potentially reducing H3K9me3 enrichment and derepressing silenced loci. As HEK293T cells already harbor oncogenic stress from SV40 large T antigen, the additional loss of HP1?? may exacerbate genome instability, offering a model to study epigenetic contributions to cancer phenotypes. The polyclonal nature reveals population-level responses, including proliferation defects and DNA damage sensitivity.
This knockout cell population enables immunofluorescence detection of HP1?? foci disruption, ChIP-qPCR for H3K9me3 changes, co-immunoprecipitation of interacting partners, and RNA-seq profiling. Functional assays such as cell proliferation, clonogenic survival, and senescence-associated ??-galactosidase staining can quantify growth and viability effects. Researchers in epigenetic silencing, chromatin biology, and cancer epigenetics will find this polyclonal resource valuable. For more information, contact Ascent Research.
